sellWeak cluster of 310b5-1 plan
BLASING KAREN sold $178k of GTLB
director at Gitlab Inc.. 3,250 shares at an average of $54.72, traded Oct 15, 2024, filed Oct 16, 2024.
Warning score
22Value
$178k
3,250 shares
Holdings after
141,233
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-24-042944, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -3,250 | $54.72 | $178k | 141,233 | Oct 16, 2024 |
Related signals
Other insiders at Gitlab Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 53Moderate | sell 2 | GTLB Gitlab Inc. | BOSTROM SUSAN L director | $2.1M | 40,000 | |
| 18Weak | sell 210b5-1 | GTLB Gitlab Inc. | BLASING KAREN director | $337k | 6,500 | |
| 12Weak | sell10b5-1 | GTLB Gitlab Inc. | BLASING KAREN director | $459k | 6,500 | |
| 11Weak | sell10b5-1 | GTLB Gitlab Inc. | BLASING KAREN director | $411k | 6,500 | |
| 55Moderate | sell 3 | GTLB Gitlab Inc. | BOSTROM SUSAN L director | $1.1M | 20,000 | |
| 75Notable | sell 5 | GTLB Gitlab Inc. | Jacobson Matthew director | $33M | 547,779 | |
| 55Moderate | sell 5 | GTLB Gitlab Inc. | BOSTROM SUSAN L director | $1.2M | 20,000 | |
| 21Weak | sell 610b5-1 | GTLB Gitlab Inc. | Schulman Robin Chief Legal Officer & Corp Sec | $168k | 2,996 | |
| 22Weak | sell 610b5-1 | GTLB Gitlab Inc. | BLASING KAREN director | $192k | 3,250 | |
| 55Moderate | sell 610b5-1 | GTLB Gitlab Inc. | Sijbrandij Sytse Executive Chair of the Board | $5.0M | 84,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.